Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert J Robichaud

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry|October 20, 2009
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3Lisa M Havran, Dan C Chong, Wayne E Childers, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonistsKevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 2010
Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonistsDerek C Cole, Jonathan L Gross, Thomas A Comery, et al.
Journal of Medicinal Chemistry|July 29, 2017
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)<sub>A</sub> ReceptorGabriel Martinez Botella, Francesco G Salituro, Boyd L Harrison, et al.
Neuropharmacology|September 25, 2020
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA<sub>A</sub> receptor positive allosteric modulatorAlison L Althaus, Michael A Ackley, Gabriel M Belfort, et al.
Bioorganic & Medicinal Chemistry|October 20, 2009
Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indolesGavin D Heffernan, Richard D Coghlan, Eric S Manas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 28, 2004
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogsSu-Er W Huskey, Brian J Dean, George A Doss, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocketLee D Jennings, Derek C Cole, Joseph R Stock, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pocketsDerek C Cole, Joseph R Stock, Rajiv Chopra, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitorsPawel Nowak, Derek C Cole, Ann Aulabaugh, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry|October 20, 2009
3,4-Dihydropyrimido(1,2-a)indol-10(2H)-ones as potent non-peptidic inhibitors of caspase-3Lisa M Havran, Dan C Chong, Wayne E Childers, et al.
Bioorganic & Medicinal Chemistry|November 25, 2010
Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT(6) antagonistsKevin G Liu, Albert J Robichaud, Alexander A Greenfield, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 2010
Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonistsDerek C Cole, Jonathan L Gross, Thomas A Comery, et al.
Journal of Medicinal Chemistry|July 29, 2017
Neuroactive Steroids. 2. 3α-Hydroxy-3β-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5β-pregnan-20-one (SAGE-217): A Clinical Next Generation Neuroactive Steroid Positive Allosteric Modulator of the (γ-Aminobutyric Acid)<sub>A</sub> ReceptorGabriel Martinez Botella, Francesco G Salituro, Boyd L Harrison, et al.
Neuropharmacology|September 25, 2020
Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA<sub>A</sub> receptor positive allosteric modulatorAlison L Althaus, Michael A Ackley, Gabriel M Belfort, et al.
Bioorganic & Medicinal Chemistry|October 20, 2009
Dual acting norepinephrine reuptake inhibitors and 5-HT(2A) receptor antagonists: Identification, synthesis and activity of novel 4-aminoethyl-3-(phenylsulfonyl)-1H-indolesGavin D Heffernan, Richard D Coghlan, Eric S Manas, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 28, 2004
The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogsSu-Er W Huskey, Brian J Dean, George A Doss, et al.
Bioorganic & Medicinal Chemistry Letters|December 11, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocketLee D Jennings, Derek C Cole, Joseph R Stock, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2007
Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pocketsDerek C Cole, Joseph R Stock, Rajiv Chopra, et al.
Bioorganic & Medicinal Chemistry Letters|December 5, 2009
Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitorsPawel Nowak, Derek C Cole, Ann Aulabaugh, et al.
Pageof 6